THANKS, DARPA:

"It was amazing at one level that we were able to produce highly effective vaccines in less than a year, but from another point of view you'd say, 'Boy, a year's a long time,'" even though in the past it would take three years or four years, Lander said. "To really make a difference we want to get this done in 100 days. And so a lot of us have been talking about a 100-day target from the recognition from a virus with pandemic potential." 

"It would mean that we would have had a vaccine in early April if that had happened this time, early April of 2020," Lander said. "It makes you gulp for a second, but it's totally feasible to do that." 

Scientists were working on so-called all-purpose ready-to-go platform technologies for vaccines long before the pandemic. They're considered "plug-and-play." Instead of using the germ itself to make a vaccine, they use messenger RNA and add the genetic code for the germ. That's what happened with the Pfizer and Moderna COVID-19 shots. 

Beyond being optimistic about confronting future pandemics, Lander wonders about the implications for preventing cancer. 

"Maybe the same sort of experience about moving so much faster than we thought is applicable to cancer," said Lander, who during the Obama administration was co-chair of the Presidential Council of Advisors on Science and Technology. A company already has been working on that. 

For that matter, the pandemic and telehealth brought the doctor to patients in some ways. Lander said he is reimagining "a world where we rearrange a lot of things" to get more patient-centered health care, including community health workers checking up every few weeks on people about their blood pressure, blood sugar and other chronic problems. 

Tweet   @brothersjudd